Refresh

MPS Pharma Ltd. - Research Center

531686 ADVIKLA Group (XT) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21

Sales

- - - 0.03 -

Operating profit

-0.39 -0.40 -0.41 -0.35 -0.32

Interest

- - - - -

Gross profit

-0.38 -0.31 -0.41 -0.35 -0.07

EPS (Rs)

-0.23 -0.19 -0.25 0.08 -0.15
Half yearly  results in details
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21

Other income

- 0.09 - - 0.25

Stock adjustment

- - - - -

Raw material

- - - 0.02 -

Power and fuel

- - - - -

Employee expenses

0.26 0.26 0.23 0.21 0.21

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

0.12 0.14 0.18 0.16 0.11

Provisions made

- - - - -

Depreciation

0.07 0.07 0.07 0.26 0.26

Taxation

-0.01 -0.01 -0.01 -0.76 -0.03

Net profit / loss

-0.44 -0.37 -0.48 0.15 -0.29

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

19.11 19.11 19.11 19.11 19.11

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

- - - -1093.52 -

GPM (%)

- - - -951.63 -

NPM (%)

- - - 407.07 -
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com